It’s been unanimously reported that African American women face a lower risk of being diagnosed with breast cancer in comparison to Caucasian women, however, they startlingly face a much higher mortality rate. Relatively younger ages at first menstruation have been reported for African American women, but the impact of this finding on breast cancer incidence has not been defined, yet an intriguing pattern of breast cancer in African American women is seen in the age-incidence curves for the disease.
Although breast cancer risk clearly increases as a function of age, African American women under the age of 45 years have a greater incidence of breast cancer than Caucasian women in this young age range. At the first sign of any lump, even if they’re very small (1 centimeter or less), of certain kinds of breast cancer tumors can still be aggressive and require maximum therapy, U.S. researchers say.
A team at the Mayo Clinic in Jacksonville, Fla., found that outcomes for women with HER2 positive (HER2+) and triple negative (HER2- and ER/PR-) tumors that have not spread to the lymph nodes may not depend on tumor size alone.
Page 1 of 3
It’s been unanimously reported that African American women face a lower risk of being diagnosed with breast cancer in comparison to Caucasian women, however, they startlingly face a much higher mortality rate. Relatively younger ages at first menstruation have been reported for African American women, but the impact of this finding on breast cancer incidence has not been defined, yet an intriguing pattern of breast cancer in African American women is seen in the age-incidence curves for the disease.
Although breast cancer risk clearly increases as a function of age, African American women under the age of 45 years have a greater incidence of breast cancer than Caucasian women in this young age range. At the first sign of any lump, even if they’re very small (1 centimeter or less), of certain kinds of breast cancer tumors can still be aggressive and require maximum therapy, U.S. researchers say.
A team at the Mayo Clinic in Jacksonville, Fla., found that outcomes for women with HER2 positive (HER2+) and triple negative (HER2- and ER/PR-) tumors that have not spread to the lymph nodes may not depend on tumor size alone.
Page 1 of 3
Read more https://blackdoctor.org/518382/even-tiny-breast-tumors-can-result-in-triple-negative-breast-cancer/